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ABSTRACT
Collaborator of alternative reading frame protein
(CARF) associates directly with ARF, p53, and/or hu-
man double minute 2 protein (HDM2), a ubiquitin-
protein ligase, without cofactors and regulates cell
proliferation by forming a negative feedback loop.
Although ARF, p53, and HDM2 also participate in the
regulation of ribosome biogenesis, the involvement
of CARF in this process remains unexplored. In this
study, we demonstrate that CARF associates with 5′-
3′ exoribonuclease 2 (XRN2), which plays a major
role in both the maturation of rRNA and the degra-
dation of a variety of discarded pre-rRNA species.
We show that overexpression of CARF increases the
localization of XRN2 in the nucleoplasm and a con-
comitant suppression of pre-rRNA processing that
leads to accumulation of the 5′ extended from of
45S/47S pre-rRNA and 5′-01, A0-1 and E-2 fragments
of pre-rRNA transcript in the nucleolus. This was
also observed upon XRN2 knockdown. Knockdown
of CARF increased the amount of XRN2 in the nu-
cleolar fraction as determined by cell fractionation
and by immnocytochemical analysis. These obser-
vations suggest that CARF regulates early steps of
pre-rRNA processing during ribosome biogenesis by
controlling spatial distribution of XRN2 between the
nucleoplasm and nucleolus.
INTRODUCTION
Alternative reading frame protein (ARF; known as p14ARF
in humans or p19ARF in mice) is involved in the p53
tumor-suppressor pathway (1) in which ARF inhibits the
ubiquitin–protein ligase Mdm2 (or HDM2), and leads to
stabilization and elevated levels of p53 (2–5). ARF also
suppresses growth of p53–Mdm2-deficient cells, suggesting
that ARF can inhibit tumor growth independently of the
p53 tumor-suppressor pathway (6). p53-independent tumor
suppression by ARF is possibly due to the ability of ARF
to suppress ribosome biogenesis by regulating the stability
of B23 (7–14).
Collaborator ofARF (CARF), whichwas identified as an
ARF-interacting protein based on yeast two-hybrid screen-
ing (15,16), is found ubiquitously in almost all human tis-
sues. CARF is mainly localized in the nucleoplasm and co-
localizes with ARF in the periphery (granular region) of
nucleoli (15), where ribosome biogenesis takes place. There-
fore, CARFmay interfere with the role of ARF in ribosome
biogenesis by interacting with ARF. CARF is involved
not only in the ARF-dependent p53 pathway but also in
the ARF-independent p53 pathway, both of which regu-
late tumor cell proliferation (15,17). In the ARF-dependent
p53 pathway, CARF directly interacts with the ubiquitin–
protein ligase Mdm2 in a complex with ARF (18,19) and
thus cooperates with ARF in activating p53 (18). In the
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ARF-independent p53 pathway, CARF directly interacts
with p53, stabilizing and functionally activating p53 (17);
however, when the amounts of CARF and the p53 complex
are elevated, these complexes are ubiquitinylated by the ac-
tion of Mdm2 and subsequently proteolytically degraded
(17). Thus, a feedback loop appears to exist in the CARF–
p53 pathway in the absence of ARF, i.e. CARF activates
p53, p53 activates Mdm2, and Mdm2 degrades CARF and
p53 (15–19). In this feedback loop, CARF can also act as
a transcriptional repressor of HDM2, the human counter-
part of Mdm2 (19). AnMdm2 inhibitor interferes with this
feedback network (20).
Overexpression of CARF induces premature senescence
in human fibroblasts (21). Similarly, replicative and stress-
induced senescence triggers an increase in CARF expres-
sion and activates the p53/p21WAF (cyclin-dependent ki-
nase inhibitor 1A) pathway (21). In contrast, CARF deple-
tion induces apoptosis and abnormal cell division in cul-
tured cells (21) and suppresses tumor growth in a human
tumor xenograft mouse model (22). CARF depletion also
affects various cell death and survival pathways, such as
those involved in mitochondrial stress, ataxia telangiecta-
sia mutated-ataxia telangiectasia and Rad3-related, Ras–
mitogen-activated protein kinase, and retinoblastoma cas-
cades (22). CARF is regulated by neuronal PAS domain
protein 2 (NPAS2), a product of the circadian NPAS2 gene
in MCF-10A cells (23). However, the molecular mecha-
nisms by which CARF is involved in premature senescence,
cell growth, and cell death remain unclear.
In this study, we examined CARF-interacting proteins
using a proteomics approach to gain insight into the role of
CARF. We show that CARF interact with 5′-3′ exoribonu-
clease 2 (XRN2) and may be implicated in the early steps of
pre-rRNA processing.
MATERIALS AND METHODS
Construction of FLAG–CARF-expressing cell lines
A doxycycline-inducible FLAG–CARF-expressing cell line
was established using the Flp-In T-Rex Expression Sys-
tem (Invitrogen, Carlsbad, CA). Briefly, Flp-In T-Rex 293
cells were cultured in one well of a 24-well plate (Thermo
Fisher Scientific, Waltham, MA). At ∼50% confluency (vi-
sually estimated based on viewing through a microscope),
they were transfected with 2 l Lipofectamine 2000 (Invit-
rogen), 250 ng plasmid pcDNA5/FRT-TO-FLAG-CARF
and pOG44 (Invitrogen). A clonal cell line was selected
in normal medium; Dulbecco’s modified Eagle’s medium
(Sigma-Aldrich, St. Louis, MO) [supplemented with 10%
heat-inactivated fetal bovine serum (Biowest LLC, Miami,
FL), 100 U/ml Penicillin G (WAKO Pure Chemicals, Os-
aka) and 100 g/ml streptomycin sulfate (WAKO Pure
Chemicals)], containing 100 g/ml hygromycin B (Invit-
rogen) and named TOCARF cells. Other cell lines stably
expressing HA–CARF (wt, N1, N2, C1, C2, and NC)–
TEV–FLAG were established by transfecting Flp-In T-
Rex 293 cells with 2 l Lipofectamine 2000, 250 ng plas-
mid pcDNA5/FRT–HA–CARF (wt, N1, N2, C1, C2, and
NC)–TEV–FLAG, and pOG44, followed by selection in
normal medium containing 100 g/ml hygromycin B. A
cell line stably expressing FLAG–Fibrillarin was also es-
tablished by transfecting Flp-In T-Rex 293 cells with 2
l Lipofectamine 2000, 250 ng plasmid pcDNA5/FRT-
FLAG-Fibrillarin and pOG44, followed by selection in nor-
mal medium containing 100 g/ml hygromycin B.
Immunoblot (IB) analysis
Proteins were separated with SDS–PAGE and elec-
trophoretically transferred to a polyvinylidene difluoride
membrane (85 mm × 55 mm; Millipore, Billerica, MA).
The membranes were blocked with 5% non-fat dried skim
milk in TBS for 1 h at 25◦C and incubated with an appro-
priate primary antibody in 1% non-fat dried skim milk in
TBS overnight at 4◦C. After washing three times with TBS
containing 0.1% (w/v) Tween 20 for 10 min, the membranes
were incubated with a secondary antibody conjugated to
alkaline phosphatase in 1% non-fat dried skim milk in
TBS for 1 h, washed three times in TBS containing 0.1%
(w/v) Tween 20 for 10 min, and washed once in TBS alone
for 5 min. Membranes were stained in staining solution,
which was prepared as a 1:50 dilution of nitro-blue tetra-
zolium chloride/5-bromo-4-chloro-3′-indolylphosphatase
p-toluidine salt stock solution (Roche Diagnostics GmbH,
Mannheim, Germany) in alkaline phosphatase buffer (100
mM Tris-HCl, pH 9.5, 100 mM NaCl, 50 mM MgCl2).
Quantification of visualized protein bands was carried out
using ImageJ software (http://rsbweb.nih.gov/ij/).
Isolation of CARF-associated complexes
TOCARF cells were cultured to 80% confluency in four
150-mm cell culture dishes in normal medium with or with-
out 1 ng/ml doxycycline for 48 h. After the cells were
washed with phosphate buffer [PBS(−)], they were lysed in
buffer A (50 mM Tris-HCl, pH 8.0; 150 mM NaCl; 0.5%
IGEPAL CA-630; 1 mM Na3VO4; and 1 mM PMSF) and
incubated on ice for 30 min. The cell extracts were obtained
as the supernatant following centrifugation of the lysate at
4◦C for 30 min at 22,180 × g. Cell extracts (15 mg) were in-
cubated with anti-FLAGM2 agarose beads (Sigma) for 4 h
at 4◦C. The beads were then washed five times in buffer A
and then once with buffer B (50 mM Tris-HCl, pH 8.0; 150
mMNaCl; 1 mMNa3VO4; and 1mMPMSF). The FLAG–
CARF-associated complexes were released from the anti-
FLAG M2 agarose beads by adding 40 l of 0.5 mg/ml
FLAG peptide (Sigma) on ice for 30 min twice.
In-gel protease digestion and liquid chromatography-tandem
mass spectrometry (LC-MS/MS) analysis (GeLC-MS/MS)
These analyses were done by methods described by
Fujiyama-Nakamura et al. (24) and Yanagida et al. (25),
and described briefly in Supplementary Materials.
Isolation of HA–XRN2-associated proteins
TOCARF cells were cultured to 25% confluency in two 90-
mm cell culture dishes in normal medium with or without
100 ng/ml doxycycline. These cells were transfected with
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10 g pcDNA3.1 (+)-HA-XRN2 using the calcium phos-
phate method (26), cultured for 24 h, and incubated fur-
ther in newmedium for 24 h. After washing with Phosphate
buffered saline (PBS), the cells were lysed in buffer A and
incubated on ice for 30 min. Cell extracts were obtained as
the supernatant following centrifugation of the lysate at 4◦C
for 30 min at 22,180 × g. The cell extracts from 1 × 107
cells were incubated with 1 g anti-HA and 15 l protein
G–Sepharose 4 Fast Flow beads (GE Healthcare) for 4 h
at 4◦C. The beads were washed six times in buffer A, and
the HA–XRN2-associated complexes were released from
the beads with 50 l SDS sample buffer (50 mM Tris-HCl,
pH 6.8; 2% SDS; 6% -mercaptoethanol; 10% glycerol; and
0.05% bromophenol blue; BPB).
Isolation of endogenous CARF- and XRN2-associated pro-
teins
Antibody-conjugated affinity beads were incubated with 1
g of normal rabbit IgG (Millipore), anti-CARF (Bethyl)
or anti-XRN2 (Bethyl) with 15 l Dynabeads protein G
(Thermo) for 1 h at room temperature. 293T cells were
cultured 90-mm cell culture dish in normal medium. Af-
ter washing with PBS, the cells were lysed in buffer A on
ice for 30 min and centrifuged at 22,180 × g at 4◦C for 30
min. The supernatant (1 mg) was incubated with antibody-
conjugated affinity beads for 3 h at 4◦C. The beads were
washed with buffer A 5 times, and the endogenous CARF
or XRN2-associated proteins were released from the beads
with 50 l SDS sample buffer.
Cell fractionation
After washing with PBS, the cells were lysed in 1ml buffer C
(16.7mMTris-HCl, pH 8.0; 50mMNaCl; 1.67mMMgCl2;
1 mMPMSF; 0.05%Triton X-100) and incubated on ice for
5 min. The cytosol was obtained as the supernatant follow-
ing centrifugation of the lysate at 4◦C for 5 min at 1,000 ×
g. The precipitate was washed with 1 ml buffer C, lysed in
0.5 ml buffer D (50 mM Tris-HCl, pH 8.0; 150 mM NaCl;
5 mM MgCl2; 1 mM PMSF), and sonicated twice for 20 s
at an interval of 90 s with a Bioruptor (Cosmo Bio, Tokyo,
Japan) at the highest setting. The nuclear extract fraction
was obtained as the supernatant following centrifugation of
this lysate at 4◦C for 15 min at 15,000 × g. The pellet was
lysed in 0.5 ml buffer D and sonicated 10 times for 20 s at
intervals of 90 s with a Bioruptor at the highest setting. The
pellet from centrifugation of this lysate at 4◦C for 30 min at
15,000 × g was lysed in 0.5 ml buffer E (50 mM Tris-HCl,
pH 8.0; 150 mMNaCl; 10 mMEDTA; 10 mMDTT; 1 mM
PMSF) and sonicated 10 times as described above. The ex-
tract fraction representing the nucleolar/Cajal bodies was
obtained as the supernatant following centrifugation of the
latter lysate at 4◦C for 30 min at 16,000&nbsp× g.
Cell fractionation for immunoprecipitation (IP)
After washing with PBS, 1.2 × 107 cells were lysed in 1 ml
buffer F (16.7 mM Tris-HCl, pH 8.0; 50 mM NaCl; 1.67
mMMgCl2; 1 mM PMSF; and 0.1% Triton X-100) and in-
cubated on ice for 3 min. The cytosol was obtained as the
supernatant following centrifugation of the lysate at 4◦C for
5 min at 1,000 × g. The precipitate was washed with 1 ml
buffer F, lysed in 0.5 ml of 50 mM Tris-HCl, pH 8.0, con-
taining 150 mM NaCl; 5 mM MgCl2; 1 mM PMSF; and
0.5% IGEPAL-CA630, and sonicated 10 times for 20 s at
an interval of 90 s with a Bioruptor at the highest setting.
Nuclear extract fraction-1 was obtained as the supernatant
following centrifugation of this lysate at 4◦C for 30 min at
16,000 × g. The precipitate was lysed in 0.5 ml buffer E
and sonicated 10 times as described above. Nuclear extract
fraction-2 was obtained as the supernatant following cen-
trifugation of the latter lysate at 4◦C for 30 min at 16,000 ×
g.
Immunocytochemical staining
Collagen-coated culture slides were prepared by adding 100
l of 50 g/ml rat tail collagen type I (Becton, Dickinson
and Company, Franklin Lakes, NJ), which was dissolved in
0.02 N acetic acid, into each well of an 8-well culture slide
(Becton, Dickinson and Company). Cells were grown on
collagen-coated culture slides that were washed with PBS.
After the culture medium was removed and the slide was
washed with PBS, the cells were fixed with 3.7% formalde-
hyde in PBS for 10 min at 25◦C. The cells were washed with
PBS containing 0.05% (w/v) Tween 20 (PBST), and perme-
abilized with PBS containing 0.5% (w/v) Triton X-100 for 5
min at 25◦C.The cells were then blockedwith 3% (w/v) non-
fat dried skimmilk in PBS for 1 h, incubatedwith the appro-
priate primary antibody for 1 h at 25◦C, washed three times
with PBST for 10 min, and incubated with a fluorochrome-
conjugated secondary antibody for 1 h at 25◦C. Finally, af-
ter being washed three times with PBST for 10 min, the cells
were mounted using VECTASHIELD Mounting Medium
with DAPI (Vector Laboratories, Burlingame, CA) and vi-
sualized with an Axiovert 200 M microscope (Carl Zeiss,
Oberkochen, Germany).
Detection of protein–protein interactions using the mKG re-
porter system
Protein–protein interactions were detected in cells using
the mKG reporter system (MBL, Nagoya, Japan) accord-
ing to the manufacturer’s instructions. Flp-In T-Rex 293
cells were cultured in collagen-coated culture slides and at
a confluency of ∼60% (visually estimated based on view-
ing through a microscope) were transfected with 1.5 l
Lipofectamine 2000 and 750 ng of the following plas-
mids: phmKGN–MC–FLAG–CARF and phmKGC–MC–
XRN2, phmKGC-MC-FLAG-CARF and phmKGN-MC-
XRN2, without plasmid as a negative control, or with
pCONT-1 and pCONT-2 (MBL) as a positive control.
The cells were fixed and permeabilized 48 h after transfec-
tion as described above and then were washed three times
with PBST. The cells were mounted using VECTASHIELD
Mounting Medium with DAPI and visualized with an Ax-
iovert 200 M microscope. The cells were immunostained
as described to detect transfected proteins. Imaging experi-
ments using themKG reporter systemwere repeated at least
twice using independent transfections.
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Northern blot hybridization
About 293T cells were cultured until 70% confluency in 35-
mm cell culture dish. Cells were transfected with scRNA
(control) or siRNA for XRN2 knockdown using Lipofec-
tamin RNAiMAX reagent (Invitrogen). After 24 h trans-
fection, the cells were cultured in 100-mm cell culture dish
for 48 h. TRex or TOCARF cells were cultured until 80%
confluency in 100-mm cell culture dish in the presence (10
ng/ml) or absence of doxycycline for 72 h.
Total RNAs were isolated from the growing sub-
confluent cells using the RNAgent Total RNA Isolation
System (Promega, Madison, WI) followed by separation
with acid phenol–chloroform extraction. The RNAs (2–2.5
g) were electrophoresed in an agarose/formaldehyde gel
and transferred to a Hybond N+ membrane (GE Health-
care). After staining with methylene blue, the membrane
was hybridized to biotin-labeled probes at 50◦C overnight
in pre-hybridization solution: 5x SSC; 20 mM Na2HPO4,
pH 7.2; 7% SDS; 2x Denhardt’s Solution (0.02% [w/v]
polyvinylpyrrolidone, Sigma-Aldrich; 0.02% [w/v] Fi-
coll, Sigma-Aldrich; 0.02% [w/v] bovine serum albumin,
Sigma-Aldrich); and 1 mg/ml salmon sperm DNA. The
membrane was washed with non-stringent wash solution
(3x SSC; 25 mM NaH2PO4, pH 7.5; 5% SDS) once for
30 min at 50◦C, and once with stringent wash solution
(1x SSC, 1% SDS) for 30 min at 50◦C. The hybridized
RNA was detected using a Chemiluminescent Nucleic
Acid Detection Module kit (Thermo Fisher Scientific).
The following oligonucleotides were used as probes to
detect human pre-rRNAs with northern blot hybridiza-
tion: 5′ external transcribed spacer (5′ ETS)-1 probe
(5′-TCGGACGCGCGAGAGAACAGCAGG-3′), com-
plementary to nt 132 to 155 of the 5′ ETS; 5′ ETS-2 probe
(5′-AGACGAGAACGCCTGACACGCACGGCAC-
3′), complementary to nt 297 to 324 of the 5′ ETS; 5′
ETS-3 probe (5′-ACAGCGACGGAGGCAATACC-3′),
complementary to nt 1468 to 1487 of the 5′ ETS; 5′
ETS-4 probe (5′-TCACGCGCCGGACAGAG-3′), com-
plementary to nt 1731 to 1747 of the 5′ ETS. ITS1-1
probe (5′-GTCTTTAAACCTCCGCGCCGGAACG
CGCTAGGTAC-3′) to nt 594 to 628 of the ITS1; 5.8S
probe (5′- AGACAGGCGTAGCCCCGGGAGGAA
-3′) to nt 123 to 146 of the 5.8S; ITS2-1 probe (5′-
ACGCCGCCGGGTCTGCGCTTA-3′) to nt 93 to 113 of
the ITS2. Probes were 3′-end labeled using a Biotin 3′-End
DNA Labeling kit (Thermo Fisher Scientific).
RESULTS AND DISCUSSION
CARF associates with XRN2
To gain insight into the role of CARF in cellular func-
tion, we examined proteins associated with CARF using
a combination of an epitope-tagged pull-down methodol-
ogy and LC-MS/MS (28). We used a site-directed (Flp-
In) recombinase-based system to generate isogenic cell lines
(27) in which a cytomegalovirus promoter was used to drive
the expression of CARF that was integrated at a common
locus in the Flp-In T-Rex 293 genome (28). A product of a
single-copy transgene ofCARFwas tagged at the amino ter-
minus with a FLAG affinity purification tag that is used for
visualization and purification. Using this approach, we ob-
tained isogenic cell lines expressing FLAG-tagged CARF
(FLAG–CARF) with a molecular weight of ∼70 kDa,
which corresponds to that estimated from its amino acid
sequence. FLAG–CARF was localized mostly in the nu-
cleoplasm (Supplementary Figure S1A) as reported (17).
We analyzed FLAG–CARF-associated proteins from TO-
CARF cell lysate using anti-FLAG mAb coupled beads.
Associated proteins were separated by SDS–PAGE, visual-
ized by silver staining and several candidate proteins were
identified by LC-MS/MS (28). Prominent amongst these
was XRN2 (Mascot protein score 1.168, 35 peptides rep-
resenting 36.5% sequence coverage, Supplementary Table
S1). Immunoblot analysis with anti-XRN2 indicated that
XRN2 corresponded to a protein band with a molecular
weight of ∼100 kDa and most strongly stained among the
proteins associated with FLAG–CARF on the SDS–PAGE
gel (Figure 1A, arrow). Although mass-based analysis did
not identify ARF, it does not necessarily mean that ARF is
not there; in a complex mixture, ARF-related peptide ion
signals may be masked/sequested by more abundant pep-
tide ion signal, or ARF may be of very low abundance. We
know minimally that the structural integrity of recombi-
nant CARF overexpressed in Flp-In T-Rex 293 cells is cor-
rect, given that FLAG–CARF can interact with HA-tagged
ARF when co-expressed in Flp-In T-Rex 293 cells (Supple-
mentary Figure S1B) (15).
To further ascertain the interaction between CARF and
XRN2, we performed an additional IP using TOCARF
cells. FLAG–CARF binding to XRN2 was increased in a
doxycycline dose-dependent manner (Figure 1B). In addi-
tion, we performed reverse pull-down analysis using HA-
tagged XRN2 (HA–XRN2) as bait and observed a recip-
rocal interaction (Figure 1C). Because CARF has a pu-
tative double-stranded RNA-binding domain (http://www.
ebi.ac.uk/interpro/protein/Q9NXV6) and XRN2 is the ho-
molog of yeast XRN2/Rat1, which processes RNAs with
its 5′-3′ exoribonuclease activity (29–32), we tested whether
they associated with each other in the presence of RNA.
We treated the immunoprecipitate obtained from the Flp-
In T-Rex 293 cells that stably expressed FLAG–CARFwith
RNase A and observed that XRN2 remained associated
with CARF even after RNase treatment (Figure 1D), in-
dicating that CARF associates with XRN2 independently
of RNA. The RNase treatment released ribosomal protein
S7 from fibrillarin, confirming the RNase activity. To rule
out the possibility that the interactions were due to over-
expression of HA–XRN2, we next immunoprecipitated en-
dogenous XRN2 from 293T cells using an antibody against
endogenous XRN2 and showed the interaction between the
two proteins (Figure 1E). We also immunoprecipitated en-
dogenous CARF from 293T cells using an antibody against
endogenous CARF, and showed reciprocal interaction be-
tween the two proteins (Figure 1E).
CARF binds directly to XRN2 in the nucleoplasm
To identify the region in CARF that was responsible for
binding to XRN2, we first constructed expression vectors
for five FLAG-tagged truncated CARF mutants (N1, N2,
C1, C2 and NC) (Figure 2A). These mutants were con-
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Figure 1. CARF associates with XRN2. (A) Using anti-FLAG, FLAG–CARF-associated complexes were immunoprecipitated from the extract of TO-
CARF cells after induction with 1 ng/ml doxycycline (dox). The FLAG–CARF-associated complexes (1 g protein/lane) were separated on a 7.5%
SDS-polyacrylamide gel and visualized with silver staining. Molecular weights (MW) are given on the left. Whole-cell lysate (WCL) were analyzed with
immunoblotting with the indicated antibodies (20 g protein/lane). (B) FLAG–CARF-associated complexes were immunoprecipitated with anti-FLAG
from TOCARF cells after induction with doxycycline (lanes 2 and 6, 0 ng/ml; lanes 3 and 7, 0.1 ng/ml; lanes 4 and 8, 10 ng/ml), and the immunoprecip-
itates from Flp-In T-Rex 293 cells (lanes 1 and 5) were analyzed with immunoblotting with the antibodies indicated on the left (IB). The input fraction
for each cell preparation (2 × 105 cells/lane) was also analyzed. (C) HA–XRN2-associated complexes were immunoprecipitated from cells with anti-HA
following treatment: induction of CARF expression with 100 ng/ml dox (lanes 1, 3, 4 and 6) and transfection with an HA–XRN2 expression plasmid
(lanes 2, 3, 5 and 6). Input fractions (2 × 105 cells/lane) and each complex were analyzed with immunoblotting using the antibodies indicated on the left.
(D) Using anti-FLAG, FLAG–CARF-associated complexes were immunoprecipitated from cells that stably expressed FLAG–CARF. Immunoprecipitates
were treated without (−) or with (+) RNase A (lanes 6 and 7). Controls were performed with Flp-In T-Rex 293 cells that were untransfected (lanes 4 and
5) and that stably expressed FLAG–fibrillarin (lanes 8 and 9). Input fractions (10 g protein/lane) and each complex were analyzed with immunoblotting
using the antibodies indicated on the left. (E) CARF- and XRN2-associated complexes were immunoprecipitated with anti-CARF and anti-XRN2 from
293T cell lysate (1 mg/1 ml), respectively (lanes 3 and 4). Normal rabbit IgG was used as a control (lane 2). Input fraction (2%) and complexes were
analyzed with immunoblotting using the antibodies indicated on the left.
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Figure 2. CARF interacts directly with XRN2. (A) Schematic representation of CARF deletion mutants and the CARF-XRN2 interaction region in
CARF. DRBM; double strand RNA-binding domain. (B) FLAG–CARF-associated complexes were immunoprecipitated with anti-FLAG from Flp-
In T-Rex 293 cells that were transfected with FLAG–CARF mutants and empty vector as control (TRex). These immunoprecipitates were analyzed
with immunoblotting using the antibodies indicated on the left. The input fraction for each cell preparation (30 g per lane) was also analyzed and
detected with the antibodies indicated on the left. The molecular sizes of molecular standards are indicated at the corresponding mobilities at right.
(C) Schematic representation of XRN2 deletion mutants and CARF–XRN2 interaction region in XRN2. (D) FLAG–CARF-associated complexes were
immunoprecipitated using anti-FLAG from TOCARF cells that were transfected with HA–XRN2 mutants or empty vector as control (M: Mock) after
inductionwith (+) orwithout (−) doxycycline (dox) (10 ng/ml) for 72 h. These immunoprecipitates were analyzedwith immunoblotting using the antibodies
indicated on the left. Input fraction of each cell preparation (20 g per lane) was also analyzed. (E) Schematic representation of the detection of protein–
protein interactions by fluorescence microscopy using the mKG reporter system in cells. mKG fluorescence was reconstituted in transfected cells when
fused to interactingN-terminal mKG fragment (mKGN)-tagged FLAG–CARF andC-terminal mKG fragment (mKGC)-taggedXRN2, or vice versa (data
not shown). (F) The interaction between FLAG–CARF and XRN2 was detected with mKG fluorescence (green) in the second panel. A combination of
mKGC–MC–XRN2 andmKGN–MC–FLAG–CARF (second panel) was examined. Flp-In T-Rex 293 cells were transfected with pCONT-1 and pCONT-
2 as positive controls on the right. DAPI: corresponding images (bottom) were stained for double-stranded DNA to indicate the nuclei. Scale bars, 10
m. (G) Flp-In T-Rex 293 cells that were transfected with mKGN-tagged FLAG–CARF and (mKGC)-tagged XRN2, or with no plasmid (as a control)
were immunostained using an anti-XRN2 (green) or anti-FLAG (red). Scale bars, 10 m. (H) Percent of mKG fluorescence-positive cells/DAPI-positive
cells. The transfection efficiency of phmKGN–MC–FLAG–CARFwas calculated using the ratio of FLAG–CARF-positive cells/DAPI-positive cells. Data
were obtained from duplicate experiments. (I) The isolated recombinant FLAG–CARF (TF–CARF–FLAG) andHA–XRN2 (TF–XRN2–TEV–HA), and
bovine serum albumin (BSA) were separated by SDS–PAGE and visualized by CBB staining (left). Binding assay was executed by mixing the recombinant
proteins and following pulldown analysis with anti-FLAG conjugated agarose resin (right).
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structed based on the exon-intron boundaries of CARF
(http://www.ncbi.nlm.nih.gov/nuccore/NM 017632.2) and
the domain structure of human CARF (http://www.ncbi.
nlm.nih.gov/protein/NP 060102.1). The expression and cel-
lular localization of the truncated proteins were examined
with SDS–PAGE and immunocytochemistry, respectively
(Figure 2B, asterisks). All truncated CARF mutants were
expressed in the cells and showed the expected molecular
sizes as estimated from their amino acid sequences (Figure
2B). IB with anti-XRN2 showed that domain mutants N1
andN2 were associated with XRN2 (Figure 2B). Those two
mutants were localized mainly in the nucleoplasm, similar
to wild-type CARF (Supplementary Figure S2A), suggest-
ing that the interaction between CARF and XRN2 occurs
in the nucleoplasm. In contrast, all other mutants lacking
the amino-terminal region corresponding to amino acids
1–175 did not associate with XRN2 (Figure 2B). Because
those mutants were not localized in the nucleoplasm (Sup-
plementary Figure S2A), we constructed additional expres-
sion vectors for C1 and C2 mutants fused to nuclear local-
ization signal (NLS) and confirmed their nuclear localiza-
tion (Supplementary Figure S2B). Those mutants, however,
did not associate with XRN2 (Supplementary Figure S2C).
Thus, N-terminal region of CARF (amino acids 1–175) is
critical for its interaction with XRN2. It is interesting that
mutant CARFs (N1 and N2), which can bind XRN2, seem
to keep the ability to localize XRN2 in the nucleoplasm
(Supplementary Figure S2A).
We next constructed expression vectors for three HA-
tagged truncated XRN2 mutants (xC, xN1 and xN2) to
identify the region in XRN2 that was responsible for
binding to CARF (Figure 2C). These truncated mutants
were constructed based on the exon-intron boundaries of
XRN2 (http://www.ncbi.nlm.nih.gov/nuccore/NM 012255.
3) and the domain structure of human XRN2 (http://www.
ncbi.nlm.nih.gov/protein/NP 036387.2). All truncated mu-
tants were localized in the nucleoplasm of their express-
ing cells (Supplementary Figure S2D) and showed the ex-
pected molecular sizes as estimated from their amino acid
sequences (Figure 2D, asterisks). IB with anti-HA showed
that domain mutant xN1 was associated with CARF (Fig-
ure 2D). Thus, the minimal region of XRN2 corresponding
to xN1 (amino acids 1–680) is necessary for the interaction
with CARF.
In addition, we used the mKG reporter system to detect
an in vivo interaction between XRN2 and CARF in Flp-
In T-Rex 293 cells. Flp-In T-Rex 293 cells were transfected
with a combination of phmKGN–MC–FLAG–CARF and
phmKGC–MC–XRN2 vectors, two empty vectors as a neg-
ative control, or pCONT-1 and pCONT-2 (MBL) as a pos-
itive control. In this system, mKG fluorescence is recon-
stituted in transfected cells when CARF and XRN2 in-
teract with each other (Figure 2E). Fluorescence was de-
tected in the nucleoplasm of Flp-In T-Rex 293 cells that
were transfected with phmKGN–MC–FLAG–CARF and
phmKGC–MC–XRN2 vectors, but not with empty vec-
tors (Figure 2F). The expression of FLAG–CARF and
XRN2 in the Flp-In T-Rex 293 cells that were trans-
fected with phmKGN–MC–FLAG–CARF and phmKGC–
MC–XRN2 vectors was confirmed with immunocytochem-
istry using anti-FLAG and anti-XRN2 antibodies (Fig-
ure 2G). The transfection efficiency of phmKGN–MC–
FLAG–CARF and phmKGC–MC–XRN2 vectors was
about 30.9% as calculated by ratio of the number of FLAG–
CARF-positive cells versus that of DAPI-positive cells
(data not shown). This efficiency was very similar to that
obtained using Flp-In T-Rex 293 cells transfected with the
positive control pCONT-1 and pCONT-2 vectors (Figure
2H). Finally, we prepared recombinant CARF–FLAG and
showed its interaction with XRN2 (Figure 2I). Coupled
with the report that human XRN2 interacts directly with
CARF (33), these data suggest that CARF interacted with
XRN2 in the nucleoplasm and that the binding does not
require cofactors.
CARF suppresses early steps of pre-rRNA processing and the
degradation of 5′-ETS fragments
XRN2 plays a major role in both the maturation of rRNA
and the degradation of the 5′-extended form of 34.5S- and
45.5S-pre-rRNAs, and in the degradation of 5′-A′ and 19S
segments, and it has also a role in degradation of the E-2
fragment, which is generated by two endonucleolytic cleav-
ages at site E and site 2 in the ITS1 region in mouse and
human cells (34–36). Thus, we postulated that CARF plays
a role in pre-rRNA processing by interacting with XRN2.
To test this idea, we first examined the effects of transient
overexpression of CARF on the processing of 5′-ETS re-
gions of pre-rRNA.We used four probes, 5′-ETS-1, 5′-ETS-
2, 5′-ETS-3 and 5′-ETS-4, to detect the 5′-ETS region with
northern blotting (Figure 3A). Overexpression of FLAG–
CARF resulted in the accumulation of 5′-01 fragments (de-
tected only with 5′-ETS-1 and 5′-ETS-2), A0-1 fragments
(detected only with 5′-ETS-4), and 47S (detected with 5′-
ETS-1 and 5′-ETS-2) relative to 28S rRNA methylene blue
staining as compared with controls that expressed only the
FLAG epitope (Supplementary Figure S3A–S3D). Consis-
tent with these results, overexpression of FLAG–CARF sig-
nificantly reduced 43S/45S/47S pre-rRNA detected with
5′-ETS-4, whereas it did not affect the processing of 30S
pre-rRNA detected with 5′-ETS-3 and -4 (Supplementary
Figure S3B). Although 30SL5′ pre-rRNA was only faintly
detected with 5′-ETS-2 and was not significantly increased
upon the transient expression of FLAG–CARF (Supple-
mentary Figure S3A), we detected significant increase of
30SL5′ pre-rRNAwith 5′-ETS-1 and 5′-ETS-2 upon the in-
creased expression of FLAG–CARF in Flp-In T-Rex cells
treated with doxycycline for 72 h (Figure 3C). In addi-
tion, we observed that the increased expression of FLAG–
CARF resulted in the accumulation of 5′-01, and 45S/47S
pre-rRNA (Figure 3B–C). We also used two additional
probes (ITS1-1 and ITS2-1) to detect ITS1 and ITS2 re-
gions by northern blotting, respectively (Figure 3A), and
showed that overexpression of FLAG–CARF also accu-
mulated 36S/30SL5′ and E-2 fragment (Figure 3D). Thus,
CARF suppresses the degradation of 5′-01, A0-1, and the
5′-extended form of 45S-pre-rRNA as well as the degra-
dation of E-2; thus, it also affects not only the processing
of 5′ETS but also the processing of ITS1. These effects of
overexpression of FLAG–CARF on the processing of pre-
rRNA were very similar to those obtained by knockdown
of XRN2 with stealth siRNAs in HeLa cells (Figures 3B–
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Figure 3. CARF suppresses the function ofXRN2 in pre-rRNAprocessing. (A) Localization of theDNAprobes within the human ribosomal transcription
unit and a schematic of pre-rRNAs detected with hybridization. Aberrant pre-rRNAs lacking 01 cleavage are underlined and denoted in gray. (B) Whole-
cell extracts fromTOCARFor TRex cells after treating with (Dox+) or without (Dox−) 10 ng/ml doxycycline for 72 h (10g per lane) or after treating with
scRNA or siRNA for XRN2 were analyzed with immunoblotting using the indicated antibodies on the left. (C) Northern blotting analysis of pre-rRNA
isolated from the cells indicated in (B). Membranes were hybridized with the oligonucleotide probes (5′ETS1, 5′ETS2, 5.8S, see A). The pre-rRNAs and
processed fragments are indicated at left based on the sizes and the specificity to the probes used. (D) Membranes were hybridized with oligonucleotide
probes (ITS1-1, ITS2-1 see A).
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D), though we did not detect the processing of the 5′end
maturation of the 28S rRNA that was also accumulated by
the knockdown of XRN2 (34). Thus, CARF plays a role in
suppressing the action of XRN2 during the processing of
pre-rRNA.
CARF retains XRN2 in the nucleoplasm
To gain insight into the mechanism by which CARF sup-
presses the action of XRN2 during the early processing
of pre-rRNA, we first examined whether CARF directly
inhibits the nucleolytic activity of XRN2 by interacting
with XRN2. We constructed expression vectors encoding
FLAG–TEV–HA-tagged XRN2 (WT) and FLAG–TEV–
HA-tagged XRN2 lacking the amino-terminal exonuclease
domain (N278) and transiently expressed them in Flp-In
T-Rex 293 cells. WT and N278 fragments were prepared
by pull-down using anti-FLAG-fixed beads (Supplemen-
tary Figure S4A). The WT protein showed nuclease activ-
ity when mixed with the synthetic RNA substrate (pSTP19
fragment), whereas the N278 protein did not (Supple-
mentary Figure S4B). We then added recombinant GST–
FLAG–CARF (Supplementary Figure S4C) to this assay
system, but we found no evidence that CARF affected the
RNase activity of XRN2 (Supplementary Figure S4B). Al-
though the construct was different, minimally the recom-
binant TF–CARF was able to bind to XRN2 (Figure 2I).
We next examined whether knockdown of CARF affects
the expression level of endogenous XRN2 orXRN2mRNA
in cells. We observed no change in the expression level of
XRN2 or XRN2 mRNA with knockdown of CARF as ex-
amined with IB using anti-XRN2 (Supplementary Figure
S4D). We also observed no change in the expression level
of endogenous XRN2 or XRN2mRNA upon doxycycline-
induced overexpression of FLAG–CARF (Supplementary
Figure S4E).
We finally considered the possibility that CARF affects
the localization of XRN2 in the cell. Thus, we examined
the cellular localization of XRN2 with immunocytochem-
istry before and after induction of FLAG–CARF in TO-
CARF cells. In the absence of induction of FLAG–CARF,
XRN2 was dispersed throughout the nucleus without a
clear boundary of its staining between the nucleoplasm and
the nucleolus as shown by co-localization images of XRN2
with nucleolar markers specific for the 3 sub-region of the
nucleolus in TOCARF cells (Figure 4A and B). In contrast,
induction of FLAG–CARF reduced the nucleolar staining
of XRN2 and revealed a clear boundary of XRN2 stain-
ing between the nucleoplasm and nucleolus (Figure 4A–
C). We treated Flp-In T-Rex 293 cells expressing FLAG–
CARF with stealth siRNA for CARF and observed dis-
persed localization of XRN2 in the nucleus of the siRNA-
treated cells when compared with the scRNA treated cells
expressing FLAG–CARF (Figure 4D). To assess the abil-
ity of CARF to further affect the localization of XRN2
in the nucleolus, we prepared the nucleolar fraction (NoE)
from the nuclear extract of siRNA- or scRNA-treatedHeLa
cells using cell fractionation and analyzed the fractions with
IB using anti-CARF and anti-XRN2. Knockdown with
siRNA reduced CARF by 70% as compared with its level
in the scRNA-treated cells and increased the proportion of
XRN2 in the NoE fraction when compared with that pre-
pared from the scRNA-treated cells (Figure 4E). The to-
tal amount of XRN2 did not differ between scRNA- and
siRNA-treated cells. Conversely, overexpression of FLAG–
CARF reduced the proportion of XRN2 in the NoE frac-
tion (Figure 4F). Thus, CARF can affect the localization of
XRN2 in the nucleolus.
In this study, we showed that XRN2 is another protein
that binds directly to CARF, in addition to ARF, p53 and
HDM2. XRN2 is a member of the eukaryotic 5PX fam-
ily of exonucleases (37) that carry out 5′ to 3′ degradation
of 5′-monophosphate-terminatingRNAsubstrates and that
are inhibited by a 5′-triphosphate or secondary structures
in RNA (30,38). XRN2 is involved in pre-rRNA process-
ing (34,35), and we also showed that CARF suppresses
the processing of 45S/47S pre-rRNA and the degradation
of 5′-01, A0-1 and E-2 fragments via its ability to retain
XRN2 in the nucleoplasm. The present data demonstrate
that CARF participates in pre-rRNA processing indepen-
dently of its action on ARF, which regulates the stability
of the rRNA-processing factor B23. Our observations con-
firmed the role of XRN2 in the processing of pre-rRNA
and the degradation of its discarded fragments as reported
by Wang & Pestov (34) and by others (35,36) and provided
more details regarding the regulatory mechanism underly-
ing mammalian pre-rRNAmaturation and decay. CARF is
expressed in all tissues (including brain, kidney, liver, lung,
pancreas, placenta, colon and ovary) and in all cell lines (in-
cluding U2OS, Saos-2, HeLa, C33A, H1299, WI38, WET,
MRC5) tested so far, except for the cell line MCF7, and its
expression level varies greatly among tissues and cell lines
(16,17). The ubiquitous presence of CARF is consistent
with its role in ribosome biogenesis, a fundamental func-
tion of the cell. Because the expression level of CARF reg-
ulates the availability of XRN2 in the nucleolus, different
expression levels of CARF are expected to differently af-
fect pre-rRNA processing in different tissues and cell lines.
Thus, we have identified a new role for CARF in the regu-
lation of the early processing of pre-rRNA and, possibly, in
the regulation of cell growth.
Previous evidence indicates that CARF has a role in both
cell growth and cell arrest. In addition, CARF overexpres-
sion results in growth arrest with no apparent signs of apop-
tosis in a cellular background lacking ARF, suggesting that
overexpression of CARF supports p53-mediated growth ar-
rest of cells independently of ARF (15). Our results provide
another possible explanation for growth arrest, in which
overexpressedCARF retainsXRN2 in the nucleoplasm and
suppresses the early steps of pre-rRNA processing. Pertur-
bation of ribosome biogenesis activates p53, which leads to
cell cycle arrest and apoptosis as reported in animal mod-
els of Treacher–Collins syndrome, a congenital disorder of
craniofacial development arising frommutations inTCOF1
(39,40). Therefore, overexpression of CARFmay perturb ri-
bosome biogenesis, leading to p53-dependent cell cycle ar-
rest. CARF interacts with p53 in the nucleoplasm, stabiliz-
ing and functionally activating p53 in the absence of ARF
(15,17). Thus, determining whether XRN2 competes with
p53 to interact with CARF in the nucleoplasm will be in-
teresting. An additional feedback loop may regulate cell
growth and arrest.
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Figure 4. CARF retains XRN2 in the nucleoplasm. (A) TOCARF cells were treated without (Dox−) and with (Dox+) doxycycline, and were immunos-
tained using an antibody against FLAG (green) and XRN2 (red). Those cells were also immunostained using an antibody against B23 (green) and XRN2
(red) in lower part. DAPI, corresponding images stained for double-stranded DNA indicating the nuclei. Scale bars, 10 m. (B) Flp-In T-Rex 293 cells
were immunostained using anti-fibrillarin (FBL) (green) and anti-XRN2 (red) (top two). These cells were also immunostained using anti-UBF (green)
and anti-XRN2 (red) (bottom two). DAPI: corresponding images were stained for double-stranded DNA to indicate the nuclei. Scale bars, 10 m. (C)
Percentage of cells without XRN2 in the nucleolus in CARF-overexpressing cells or in cells expressing normal levels of CARF. Statistical significance was
evaluated using the Student’s t-test. P< 0.01. (D) Flp-In T-Rex 293 cells stably expressing HA–CARF–TEV FLAGwere transfected with siRNA targeting
CARF (bottom) or control scRNA (top) and were immunostained using anti-XRN2 (green) or anti-FLAG (red). These cells were also immunostained
with anti-fibrillarin (red) (bottom two). DAPI: corresponding images stained for double-stranded DNA to indicate the nuclei. Scale bars, 10 m. (E) Cells
that were transfected with scRNA (−) or siRNA targeting CARF (+) were fractionated into cytosolic (Cy) and the nuclear extracts (Nu), the latter of
which was used to prepare the nucleolar fraction (NoE) using cell fractionation. These fractions and WCL (10 g protein per lane) were analyzed with
immunoblotting using the antibodies indicated on the left. The proportion of XRN2 staining intensity of siRNA lane to total protein amount per lane was
also normalized to that of scRNA lane. The results of immunoblotting were quantified and shown in a graph. Mean values (±SD) from three independent
experiments are shown. *P < 0.05; **P < 0.01. (F) Flp-In T-Rex 293 cells stably expressing HA–CARF–TEV FLAG or Flp-In T-Rex 293 cells (−) were
fractionated and analyzed as in E. The proportion of XRN2 staining intensity of FLAG–CARF (+) lane to total protein amount per lane was normalized
to that of Flp-In T-Rex 293 cells (−) lane.
Finally, in yeast, XRN2 is required for efficient termina-
tion by RNA polymerase I on the rDNA in cooperation
with its cofactor Rai1 (32). Thus, CARF may also affect
the termination of rDNA transcription. XRN2 is associ-
ated with lung cancer (41), and XRN2 transcription is re-
pressed by hypermethylation in adenoid cystic carcinoma
(42). Thus, the association of CARF with XRN2 may have
therapeutic potential as a novel tumor-suppressing target of
anti-cancer reagents.
It is interesting to note the recent finding by Watanabe
et al. that in HeLa cells mTOR regulates the diffusion of
XRN2 from the nucleolus to the nucleoplasm under heat
stress conditions and that this, in turn, may affect transla-
tional suppression throughmTOR-regulated iMet degrada-
tion (43). It is interesting to speculate that heat stress and/or
mTOR signaling affects the expression levels of nuclear
CARF and XRN2 redistribution. Based on our present re-
sults, we suppose that this redistribution causes the sup-
pression of early pre-rRNA processing. At the same time,
it is also interesting to know whether ARF is diffused from
the nucleolus to the nucleoplasm under the condition of
heat stress. If ARF was diffused to the nucleoplasm, it is
likely thatARF–CARFandCARF–XRN2 interactions oc-
cur simultaneously in the nucleoplasm. It will be very im-
portant to know whether the ARF–CARF interaction pre-
clude CARF–XRN2 interaction in terms of negative feed-
back network amongARF, p53,Mdm2 and CARF asmen-
tioned in INTRODUCTION. Clearly, a better understand-
ing of CARF/XRN2 interactions and how XRN2 redis-
tribution in the nucleus impacts on pre-rRNA processing
may have far reaching therapeutic potential leading to novel
tumor-suppressing targets.
During revision of this manuscript, Miki et al. reported
that PAXT-1, a C. elegans homolog of human CARF,
bound and stabilized XRN2 (33). Consistent with our
present result, the binding did not alter the enzymatic ac-
tivity of XRN2. In C. elegans, however, the two proteins
regulate mutually their cellular levels, i.e. the elevated level
of PAXT-1 stabilizes XRN2 and promotes its nuclease ac-
tivity that is required for efficient degradation of miRNAs,
whereas the reduced level of XRN2decreases that of PAXT-
1. These functions seem to be essential for the development
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of C. elegans (33). On the contrary, we did not observe the
effect of the overexpressed CARF on stabilization of XRN2
in human cells we used so far. We are not sure at present
whether those differences are species specific, cell specific
or developmental stage specific ones. Since CARF partic-
ipates in negative feedback loops through interaction with
the other proteins includingMdm2, p53 andARF in human
cells, it is likely that the cellular levels of human CARF and
XRN2 are regulated differently from those of C. elegans.
Since XRN2 shows the nuclease activity on a number of
different substrates, our present study possibly provides a
mechanism by which CARF regulates the nuclease activity
of XRN2 in substrate specific manner.
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